Epigenomic marks and complexes contribute to development and disease. This session covers the convergence of pathogenic variants with epigenomics and epitranscriptomics. Novel approaches to detect differential DNA methylation and variant classification are evaluated. The malleability of the epigenome to reverse clinical features of developmental disorders is examined.
Learning Objectives: 1. Assess novel relationships between the histone modification landscape and epigenomic functions. 2. Evaluate m6A methylation relative to brain development and disease. 3. Summarize the genetic impact of DNA methylation changes shared across multiple tissues. 4. Compare sequencing technologies' ability to detect rare methylation differences from genome data. 5. Define single-cell methods for variant classification in rare epilepsies. 6. Evaluate the in utero malleability of Wiedemann-Steiner syndrome.